NCT01774864View on ClinicalTrials.gov

Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Erectile Dysfunction
Interventions
DRUG

DA-8159 (Udenafil)

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY